Ignite Creation Date:
2025-12-24 @ 1:35 PM
Ignite Modification Date:
2026-02-22 @ 4:50 PM
Study NCT ID:
NCT03645395
Status:
TERMINATED
Last Update Posted:
2022-08-16
First Post:
2018-07-19
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Dose Regimens of MT-3724 With Lenalidomide for the Treatment of Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (MT-3724_NHL_003)
Sponsor:
Molecular Templates, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MT-3724_NHL_003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None